| 000 | 01190 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516071431.0 | ||
| 264 | 0 | _c20120615 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1619-7089 | ||
| 024 | 7 |
_a10.1007/s00259-011-2027-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHacker, M | |
| 245 | 0 | 0 |
_aMonitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cMar 2012 |
||
| 300 |
_a396-8 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAbdominal Fat _xdrug effects |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aArteritis _xdrug therapy |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 |
_aVascular Calcification _xdrug therapy |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 39 _gno. 3 _gp. 396-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-011-2027-2 _zAvailable from publisher's website |
| 999 |
_c21410850 _d21410850 |
||